Melt-derived bioactive glass scaffolds produced by a gel-cast foaming technique.

Porous melt-derived bioactive glass scaffolds with interconnected pore networks suitable for bone regeneration were produced without the glass crystallizing. ICIE 16 (49.46% SiO(2), 36.27% CaO, 6.6% Na(2)O, 1.07% P(2)O(5) and 6.6% K(2)O, in mol.%) was used as it is a composition designed not to crystallize during sintering. Glass powder was made into porous scaffolds by using the gel-cast foaming technique. All variables in the process were investigated systematically to devise an optimal process. Interconnect size was quantified using mercury porosimetry and X-ray microtomography (μCT). The reagents, their relative quantities and thermal processing protocols were all critical to obtain a successful scaffold. Particularly important were particle size (a modal size of 8 μm was optimal); water and catalyst content; initiator vitality and content; as well as the thermal processing protocol. Once an optimal process was chosen, the scaffolds were tested in simulated body fluid (SBF) solution. Amorphous calcium phosphate formed in 8h and crystallized hydroxycarbonate apatite (HCA) formed in 3 days. The compressive strength was approximately 2 MPa for a mean interconnect size of 140 μm between the pores with a mean diameter of 379 μm, which is thought to be a suitable porous network for vascularized bone regeneration. This material has the potential to bond to bone more rapidly and stimulate more bone growth than current porous artificial bone grafts.

[1]  J. Binner,et al.  Production of porous hydroxyapatite by the gel-casting of foams and cytotoxic evaluation. , 2000, Journal of biomedical materials research.

[2]  J. Binner,et al.  Evaluation of the in situ polymerization kinetics for the gelcasting of ceramic foams , 2001 .

[3]  Larry L. Hench,et al.  Analysis of pore interconnectivity in bioactive glass foams using X-ray microtomography , 2004 .

[4]  F. S. Ortega,et al.  Properties of Highly Porous Hydroxyapatite Obtained by the Gelcasting of Foams , 2000 .

[5]  Dominique Bernard,et al.  Non-destructive quantitative 3D analysis for the optimisation of tissue scaffolds. , 2007, Biomaterials.

[6]  Larry L. Hench,et al.  Bioglass ®45S5 Stimulates Osteoblast Turnover and Enhances Bone Formation In Vitro: Implications and Applications for Bone Tissue Engineering , 2000, Calcified Tissue International.

[7]  N. Skovgaard Safety evaluation of certain food additives and contaminants , 2000 .

[8]  J. Binner,et al.  Persulfate−Amine Initiation Systems for Gelcasting of Ceramic Foams , 2001 .

[9]  H. Oonishi,et al.  Comparative bone growth behavior in granules of bioceramic materials of various sizes. , 1999, Journal of biomedical materials research.

[10]  Julian R Jones,et al.  Synchrotron X-ray microtomography for assessment of bone tissue scaffolds , 2010, Journal of materials science. Materials in medicine.

[11]  Inorganic oxide glasses as ionic polymers , 1975 .

[12]  Julian R Jones,et al.  Optimising bioactive glass scaffolds for bone tissue engineering. , 2006, Biomaterials.

[13]  T Kitsugi,et al.  Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. , 1990, Journal of Biomedical Materials Research.

[14]  T. Buslaps,et al.  In situ high-energy X-ray diffraction study of a bioactive calcium silicate foam immersed in simulated body fluid. , 2007, Journal of synchrotron radiation.

[15]  Julian R. Jones,et al.  Large-Scale Production of 3D Bioactive Glass Macroporous Scaffolds for Tissue Engineering , 2004 .

[16]  L. Hench,et al.  The use of advanced diffraction methods in the study of the structure of a bioactive calcia: silica sol-gel glass , 2006 .

[17]  Ross T. Whitaker,et al.  Partitioning 3D Surface Meshes Using Watershed Segmentation , 1999, IEEE Trans. Vis. Comput. Graph..

[18]  L L Hench,et al.  Effect of crystallization on apatite-layer formation of bioactive glass 45S5. , 1996, Journal of biomedical materials research.

[19]  Larry L. Hench,et al.  Regeneration of trabecular bone using porous ceramics , 2003 .

[20]  Aldo R Boccaccini,et al.  45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. , 2006, Biomaterials.

[21]  Julian R Jones,et al.  Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[22]  A. Boccaccini,et al.  Structural analysis of bioactive glasses , 2005 .

[23]  Larry L. Hench,et al.  The sol-gel process , 1990 .

[24]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .

[25]  D. Qiu,et al.  A study of the formation of amorphous calcium phosphate and hydroxyapatite on melt quenched Bioglass® using surface sensitive shallow angle X-ray diffraction , 2009, Journal of materials science. Materials in medicine.

[26]  W. S. Pietrzak,et al.  Calcium sulfate bone void filler: a review and a look ahead. , 2000, The Journal of craniofacial surgery.

[27]  Julian R. Jones,et al.  An atomic scale comparison of the reaction of Bioglass® in two types of simulated body fluid , 2009 .

[28]  L L Hench,et al.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. , 2001, Journal of biomedical materials research.

[29]  Delbert E Day,et al.  Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. , 2008, Acta biomaterialia.

[30]  J. Binner,et al.  Processing of cellular ceramics by foaming and in situ polymerisation of organic monomers , 1999 .

[31]  Ogbemi O. Omatete,et al.  Gelcasting: From laboratory development toward industrial production , 1997 .